Solid and non-solid tumors, tumor development, progression and therapy are addressed in this emphasis. Multiscale research from cells to humans is covered that focuses on the mechanistic investigation of cancer-related biological processes, probe development and novel diagnostic and therapeutic applications.
Probes & Targets
The design, chemical synthesis and characterization of imaging probes or reporter genes and their targets prior to in vivo applications. Research targeting new biological mechanisms where imaging is used as a tool to gain mechanistic insights into disease are included. All imaging modalities covered.
Preclinical Imaging
All applications where new imaging tools, probes and therapeutics are evaluated in preclinical models belong to this category. It also includes the preclinical testing of image-guided therapies.
Translational and Human Studies
Research on humans or (non-human) studies with demonstrated potential for clinical impact or immediate translation should be submitted to this category. It includes prospective and retrospective studies as well as studies on new pharmaceuticals at phase I-IV where imaging plays a significant role in the study. Studies on Omics and its combination with imaging are also welcome.
Image-guided Therapy and Theranostics
Research covering theranostic repurposing of existing molecular imaging probes, applications where imaging is used to plan treatment and/or to monitor response to treatment, as well as novel approaches to integrate molecular imaging with conventional therapy are included under this category. Preclinical testing of theranostic agents/strategies and human translational applications are covered.